← All investors

Aisling Capital
40 portfolio companies · 3 on the map · $2.7B raised · 3 cities
Portfolio map
3 Aisling Capital portfolio companies on the map.
Portfolio companies

ESPERION THERAPEUTICS
Ann Arbor
Esperion discovers and develops pharmaceutical products for the treatment of cardiovascular and metabolic diseases.
Pharmaceutical Manufacturing$1.2BEst. 2008
Compass Pathways
London
Compass Pathways is a mental health care company that focuses on developing therapies for treatment-resistant depression.
Mental Health Care$771.2MEst. 2016
Scholar Rock
Cambridge
Scholar Rock is a biopharmaceutical company that develops and discovers new medicines and treatments for the serious diseases.
Biotechnology$743MEst. 2012
More portfolio companies
37 more Aisling Capital investments we track beyond the map.
Forge BiologicsGrove City · Series C
Biomea FusionRedwood City · Series A
Treeline BiosciencesWatertown · Series A
BridgeBioPalo Alto · Series D
Dren BioFoster City · Series B
GondolaBioPalo Alto · Venture
Ajax HealthMenlo Park · Series C
Ascendis PharmaPalo Alto · Post-IPO Equity
CalciMedicaLa Jolla · Post-IPO Equity
Promentis PharmaceuticalsMilwaukee · Series C
VIVUSMountain View · Post-IPO Equity
Poseida TherapeuticsSan Diego · Series C
PharmaronBeijing · Series C
AtrecaSouth San Francisco · Series C
ChimerixDurham · Venture
ObsEvaPlan-les-ouates · Post-IPO Equity
DermiraMenlo Park · Series C
Aeglea BioTherapeuticsAustin · Post-IPO Equity
Aimmune TherapeuticsBrisbane · Series B
Eidos TherapeuticsPalo Alto · Series B
Infinity PharmaceuticalsCambridge · Post-IPO Equity
Nabriva TherapeuticsVienna · Post-IPO Debt
Intersect ENTMenlo Park · Venture
Zosano PharmaFremont · Post-IPO Equity
GTxMemphis · Post-IPO Equity
LENSAROrlando · Private Equity
Roka BioscienceWarren · Series D
Miramar LabsSunnyvale · Venture
Sirion TherapeuticsTampa · Series B
CempraChapel Hill · Series C
Aton PharmaLawrenceville · Seed
XanodyneNewport · Venture
PreCision DermatologyCumberland · Venture
Axcan PharmaceuticalsMont-saint-hilaire · Venture
Zeltiq AestheticsPleasanton · Series D
FBG LimitedBarton Upon Humber · Venture
Bridge PharmaceuticalsGaithersburg · Series B
Portfolio map
3 Aisling Capital portfolio companies on the map.